By Emma Spencer, Science & Technology Reporter

Pregnancy can be an emotional journey, and many Sacramento-area expectant mothers say depression is one of the intense feelings they face along the way. That’s why many are asking: are antidepressants safe, or are more holistic alternatives the better route?

Now, a new FDA panel is raising tough questions about the safety of SSRIs during pregnancy, with experts urging stronger warning labels and deeper conversations about non-drug alternatives.

In a rare public panel, FDA officials and medical experts gathered to debate a growing concern: whether popular antidepressants like Zoloft, Lexapro, and Prozac are putting unborn babies at risk when taken during pregnancy. While some on the panel defended SSRIs as necessary treatment for depression, others pointed to a mounting stack of research linking them to birth defects, premature labor, and long-term developmental effects in children.

FDA Commissioner Martin Makary acknowledged that serotonin, which SSRIs target, plays a crucial role in fetal development and may be disrupted by the drugs. Some panelists cited links to birth defects, autism, ADHD, and even adolescent depression in children exposed to SSRIs in the womb. Others pushed back, warning that untreated maternal depression also raises serious risks, including preterm delivery and maternal suicide. Several doctors criticized the current FDA drug labels as outdated and misleading, calling for more transparency on risks like postpartum hemorrhage, preeclampsia, and withdrawal. One expert likened the current state of SSRI use in pregnancy to a mass medical experiment lacking informed consent.

“SSRIs cross the placenta and disrupt the serotonin system. That system helps shape the brain. If we mess with that during fetal development, we shouldn’t be surprised by what follows.”
—Dr. Adam Urato, Maternal-Fetal Medicine Specialist

Some panelists highlighted promising alternatives: cognitive behavioral therapy, nutritional support (like omega-3s and B vitamins), and other non-pharma strategies that don’t cross the placenta or alter fetal brain chemistry.

As the FDA considers updating warning labels, the question remains: are pregnant women being told the full story? And when it comes to mental health, are there safer ways forward than defaulting to pills?